Novo Nordisk shares are rising. The FDA approves another use for Wegovy.

Novo Nordisk shares are rising. The FDA approves another use for Wegovy.



Novo Nordisk shares are rising. The FDA approves another use for Wegovy.
The FDA approved Wegovy for use in a form of liver disease.


www.marketwatch.com
#Novo #Nordisk #shares #rising #FDA #approves #Wegovy

Share: X · Facebook · LinkedIn

Leave a Reply

Your email address will not be published. Required fields are marked *